EMAIL THIS PAGE TO A FRIEND

Science translational medicine

Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.


PMID 24848257

Abstract

Suppression of the host's immune system plays a major role in cancer progression. Tumor signaling of programmed death 1 (PD1) on T cells and expansion of myeloid-derived suppressor cells (MDSCs) are major mechanisms of tumor immune escape. We sought to target these pathways in rhabdomyosarcoma (RMS), the most common soft tissue sarcoma of childhood. Murine RMS showed high surface expression of PD-L1, and anti-PD1 prevented tumor growth if initiated early after tumor inoculation; however, delayed anti-PD1 had limited benefit. RMS induced robust expansion of CXCR2(+)CD11b(+)Ly6G(hi) MDSCs, and CXCR2 deficiency prevented CD11b(+)Ly6G(hi) MDSC trafficking to the tumor. When tumor trafficking of MDSCs was inhibited by CXCR2 deficiency, or after anti-CXCR2 monoclonal antibody therapy, delayed anti-PD1 treatment induced significant antitumor effects. Thus, CXCR2(+)CD11b(+)Ly6G(hi) MDSCs mediate local immunosuppression, which limits the efficacy of checkpoint blockade in murine RMS. Human pediatric sarcomas also produce CXCR2 ligands, including CXCL8. Patients with metastatic pediatric sarcomas display elevated serum CXCR2 ligands, and elevated CXCL8 is associated with diminished survival in this population. We conclude that accumulation of MDSCs in the tumor bed limits the efficacy of checkpoint blockade in cancer. We also identify CXCR2 as a novel target for modulating tumor immune escape and present evidence that CXCR2(+)CD11b(+)Ly6G(hi) MDSCs are an important suppressive myeloid subset in pediatric sarcomas. These findings present a translatable strategy to improve the efficacy of checkpoint blockade by preventing trafficking of MDSCs to the tumor site.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1300799
Anti-α-Synuclein (N-term) antibody produced in rabbit, saturated ammonium sulfate (SAS) precipitated, buffered aqueous solution
S3062
Anti-α-Synuclein antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
S5566
Anti-α-Synuclein antibody, Mouse monoclonal, clone Syn211, purified from hybridoma cell culture
SAB2502034
Anti-Cxcr2 (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1406027
Anti-CXCR2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2900183
Anti-CXCR2 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2103792
Anti-IL8RB, (N-terminal) antibody produced in rabbit, affinity isolated antibody
PRS4065
Anti-PD-1 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS4067
Anti-PD-1 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900280
Anti-PDCD1 (AB1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900373
Anti-PDCD1 (AB2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2500763
Anti-PDCD1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1400196
Anti-PDCD1 antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
HPA035981
Anti-PDCD1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4300502
Anti-SNCA (Ab-125) antibody produced in rabbit, affinity isolated antibody
SAB4300445
Anti-SNCA (Ab-129) antibody produced in rabbit, affinity isolated antibody
SAB4300528
Anti-SNCA (Ab-133) antibody produced in rabbit, affinity isolated antibody
SAB2502111
Anti-SNCA antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2502112
Anti-SNCA antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2102253
Anti-SNCA antibody produced in rabbit, affinity isolated antibody, lyophilized powder
HPA005459
Anti-SNCA antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1105828
Anti-SPATA2 (341-354) antibody produced in rabbit, IgG fraction of antiserum
SAB1410026
Anti-SPATA2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA048581
Anti-SPATA2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2107365
Anti-SPATA2 antibody produced in rabbit, affinity isolated antibody
SAB1411697
Anti-SPATA2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4700360 Monoclonal Anti-CD25 antibody produced in mouse, clone MEM-181, purified immunoglobulin, buffered aqueous solution
SAB4700365 Monoclonal Anti-CD25 antibody produced in mouse, clone MEM-140, purified immunoglobulin, buffered aqueous solution
SAB1305503
MONOCLONAL ANTI-CD25 antibody produced in mouse, clone 7G7B6, crude ascites, buffered aqueous solution
WH0003559M4
Monoclonal Anti-IL2RA antibody produced in mouse, clone 1D6, purified immunoglobulin, buffered aqueous solution